Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in Ohio: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Tepezza Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Tepezza (teprotumumab) in Ohio, with coverage limited to 8 lifetime infusions for moderate-to-severe thyroid eye disease. You'll need a Clinical Activity Score (CAS) ≥3, euthyroid thyroid labs, and documented steroid failure or contraindication. Submit
7 min read

How to Get Jakafi (Ruxolitinib) Covered by UnitedHealthcare in Washington: Complete Guide to Prior Authorization, Appeals, and IRO Review

Answer Box: Getting Jakafi (Ruxolitinib) Covered by UnitedHealthcare in Washington Jakafi (ruxolitinib) requires prior authorization from UnitedHealthcare, but approval is achievable with proper documentation. For myelofibrosis, provide intermediate/high-risk diagnosis evidence and symptom documentation. For polycythemia vera, document hydroxyurea failure or intolerance. Submit via the UnitedHealthcare provider portal with complete
6 min read

Work With Your Doctor to Get Pemazyre (pemigatinib) Covered by UnitedHealthcare in Florida: Complete Provider Collaboration Guide

Answer Box: Getting Pemazyre Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Pemazyre (pemigatinib) with FGFR2 fusion testing, prior therapy documentation, and ophthalmology monitoring plan. Work with your oncologist to submit: FDA-approved FGFR2 test results, gemcitabine/cisplatin failure records, baseline eye exam, and treatment plan via UHC Provider
6 min read

How Long Does It Take to Get Abecma (Idecabtagene Vicleucel) Approved by UnitedHealthcare in Ohio? Complete Timeline Guide

Answer Box: Getting Abecma Approved by UnitedHealthcare in Ohio UnitedHealthcare typically approves Abecma (idecabtagene vicleucel) within 5-15 business days for relapsed/refractory multiple myeloma patients who meet FDA criteria (≥2 prior lines including IMiD, proteasome inhibitor, and anti-CD38 antibody). Submit through the medical benefit via UnitedHealthcare Provider Portal with complete
6 min read

How to Get Humate-P Covered by UnitedHealthcare in New Jersey: Prior Authorization, Appeals, and State Protections

Answer Box: Getting Humate-P Covered by UnitedHealthcare in New Jersey Humate-P (antihemophilic factor/vWF complex) requires prior authorization from UnitedHealthcare through OptumRx. New Jersey's strengthened step therapy protections (effective January 2026) and external review system provide strong patient safeguards. First step today: Have your hematologist document your VWD
6 min read

Requirements Checklist to Get Dupixent (dupilumab) Covered by UnitedHealthcare in Ohio: Forms, Appeals, and Cost-Saving Strategies

Answer Box: Ohio patients need prior authorization through OptumRx for Dupixent coverage by UnitedHealthcare. Submit via provider portal with diagnosis documentation, step therapy failures (topicals for atopic dermatitis, high-dose ICS/LABA for asthma), and medical necessity letter. If denied, appeal within 21 days internally, then external review through Ohio Department
5 min read

How to Get Mavenclad (cladribine tablets) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad Covered in North Carolina UnitedHealthcare requires prior authorization for Mavenclad (cladribine tablets) for relapsing MS, with no explicit step therapy but strict criteria including lymphocyte count ≥800 cells/μL and documented prior DMT failure. If denied, you have 180 days for internal appeals, then 120 days
6 min read

Getting Poteligeo (mogamulizumab-kpkc) Covered by UnitedHealthcare in Texas: Prior Authorization Requirements and Appeals Guide

Answer Box: Fast Track to Poteligeo Coverage UnitedHealthcare requires prior authorization for Poteligeo (mogamulizumab-kpkc) in Texas, with approval based on confirmed mycosis fungoides/Sézary syndrome diagnosis and failure of ≥1 prior systemic therapy. Your oncologist or hematologist must submit documentation through the UHC Provider Portal showing step therapy completion (extracorporeal
6 min read

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tepezza Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Tepezza (teprotumumab) with specific criteria: moderate-to-severe thyroid eye disease (CAS ≥3), euthyroid status, and documented steroid failure or contraindication. Submit through the UHC Provider Portal with complete documentation including Clinical Activity Score, thyroid labs, and
7 min read